Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease

Circulation: Heart Failure

Volumn 6, Issue 3, 2013, Pages 443-450

  Doenst, Torsten ^a   Cleland, John G F ^b   Rouleau, Jean L ^c   She, Lilin ^e   Wos, Stanislaw ^f   Ohman, E Magnus ^d,e   Krzeminska Pakula, Maria ^g   Airan, Balram ^h   Jones, Robert H ^d,e   Siepe, Matthias ⁱ   Sopko, George ^j   Velazquez, Eric J ^d,e   Racine, Normand ^c   Gullestad, Lars ^k   Filgueira, Jose Luis ^l   Lee, Kerry L ^d,e  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HULL   (United Kingdom)

^c MONTREAL HEART INSTITUTE   (Canada)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l Instituto Nacional de Transplantes   (Uruguay)

more..

Author keywords

Coronary bypass surgery; Heart failure; Medical therapy

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CLINICAL DECISION MAKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FAMILY DECISION MAKING; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC HEART FAILURE;

CORONARY BYPASS SURGERY; HEART FAILURE; MEDICAL THERAPY;

AGED; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CROSS-OVER STUDIES; DISEASE PROGRESSION; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED;

EID: 84879199573     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000130     Document Type: Article

References (12)

1. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL; STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705-1717.
2. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, Mock MB, Pettinger M, Robertson TL. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629-1646.
3. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL; STICH Investigators. Coronaryartery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607-1616.
4. Velazquez EJ, Lee KL, O'Connor CM, Oh JK, Bonow RO, Pohost GM, Feldman AM, Mark DB, Panza JA, Sopko G, Rouleau JL, Jones RH; STICH Investigators. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg. 2007;134:1540-1547.
5. Jones RH, White H, Velazquez EJ, Shaw LK, Pietrobon R, Panza JA, Bonow RO, Sopko G, O'Connor CM, Rouleau JL. STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. J Am Coll Cardiol. 2010;56:490-498.
6. Cleland JG. Beta-blockers for heart failure: why, which, when, and where. Med Clin North Am. 2003;87:339-371.
7. Yusuf S, Pogue J. ACE inhibition in stable coronary artery disease. N Engl J Med. 2005;352:937-9; author reply 937.
8. Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J. 2004;148:157-164.
9. Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR; WATCH Trial Investigators. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009;119:1616-1624.
10. Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P; CORONA Study Group. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Eur Heart J. 2012;33:2290-2296.
11. Latini R, Gullestad L, Masson S, Nymo SH, Ueland T, Cuccovillo I, Vårdal M, Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L; Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. Eur J Heart Fail. 2012;14:992-999.
12. Fisher LD, Kaiser GC, Davis KB, Mock MB